Arkolith/Insider Trading/AVXL/Form 4

Skarpelos Athanasios

DirectorANAVEX LIFE SCIENCES CORP. (AVXL) · full profile →Form 4 · filed May 27, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$453K
Net Open-Market Flow
-$453K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 25, 2022Option exercise(M)50K$0.92$46K1.4M
May 25, 2022Sell(S)50K$9.06$453K1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 25, 2022Option exercise(M)50K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-22-001013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ANAVEX LIFE SCIENCES CORP.

Build

Ask your agent about AVXL insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001731122-22-001013"
Ask your agent
Use Arkolith to summarize insider buying and selling at ANAVEX LIFE SCIENCES CORP.
over the last 90 days and cite the filings.